Zacks Investment Research·1d ago
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?Here is how Acadia Healthcare (ACHC) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year.
Acadia Healthcare's revenue growth has stalled at -0.4% YoY in Q2 2026, with gross margins compressing to 16.6% from 96.7% a year earlier, reflecting cost reclassification and labor inflation.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 4, 2026 | $0.60+29.7% vs $0.46 | $895M+2.0% vs $878M |
Q3 2026 Jul 28, 2026 | $0.38+9.7% vs $0.35 | $866M+2.6% vs $844M |
Q2 2026 Apr 29, 2026 | $0.37+32.1% vs $0.28 | $829M+0.6% vs $824M |
Q1 2026 Feb 25, 2026 | $0.07+133.3% vs $0.03 | $821M+2.7% vs $800M |
Here is how Acadia Healthcare (ACHC) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year.
Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC - Get Free Report)'s share price hit a new 52-week high during trading on Thursday after the company announced better than expected quarterly earnings. The company traded as high as $39.38 and last traded at $36.8190, with a volume of 485,555 shares. The stock had previously closed at $32.25. The
Acadia Healthcare NASDAQ: ACHC raised its full-year 2026 financial guidance for the third consecutive quarter after reporting third-quarter revenue growth and stronger-than-expected adjusted earnings, executives said on the company's earnings call.
Benchmark ACHC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Acadia Healthcare Company, Inc. (ACHC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $37.00 | $3.44B | -3.01 | 5.04% | -33.07% | -51.55% | — | |
| $195.50 | $11.83B | 7.91 | 9.71% | 7.96% | 19.27% | 0.41% | |
| $23.20 | $3.03B | -33.73 | 6.24% | -2.63% | -2.59% | — | |
| $9.01 | $2.15B | -57.46 | 4.77% | -1.27% | — | — | |
| $181.08 | $10.55B | 26.91 | 18.72% | 7.03% | 16.61% | 0.14% | |
| $494.99 | $107.17B | 15.87 | 7.08% | 8.61% | — | 0.59% |
Acadia Healthcare Company, Inc. (ACHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Acadia Healthcare Company, Inc. (ACHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 28, 2026·SEC
May 18, 2026·SEC
May 6, 2026·SEC
Get notified when ACHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Acadia Healthcare Company, Inc. (ACHC) stock FAQ — growth, dividends, profitability & financials explained
Acadia Healthcare Company, Inc. (ACHC) reported $3.41B in revenue over the trailing twelve months. Revenue was $3.31B in fiscal year 2025. That is 1396% more than the $221.4M of fiscal year 2011.
Acadia Healthcare Company, Inc. (ACHC) grew revenue by 4.5% over the trailing twelve months, compared with the twelve months before.
No. Acadia Healthcare Company, Inc. (ACHC) reported a net loss of $1.13B over the trailing twelve months.
Acadia Healthcare Company, Inc. (ACHC) had a return on equity (ROE) of -51.5% over the trailing twelve months. A negative ROE means the company lost money over the period.
Acadia Healthcare Company, Inc. (ACHC) generated $91.3M in free cash flow over the trailing twelve months.
